Evidence map›Paper›PMID 34854938›Full record

ArticleApplied microbiology and biotechnology2022

The inhibitory effect of rBCG on EB virus-positive tumours using an EB virus fusion gene.

Qing-Jie Xue, Hong-Xia Yu, Ang Liu, Hui Wang, Yun-Qing Li, Ting Chen, Qiu-Ling Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Qing-Jie XueDepartment of Pathogenic Biology, Jining Medical University, Shandong, 272067, China.ORCID http://orcid.org/0000-0001-5561-4091
Hong-Xia YuDepartment of Infectious Disease, Yantai Yuhuangding Hospital, Shandong, 264000, China.
Ang LiuDepartment of Pathogenic Biology, Jining Medical University, Shandong, 272067, China.
Hui WangDepartment of Pathogenic Biology, Jining Medical University, Shandong, 272067, China.
Yun-Qing LiDepartment of Pathogenic Biology, Jining Medical University, Shandong, 272067, China.
Ting ChenDepartment of Pathogenic Biology, Jining Medical University, Shandong, 272067, China. Chenting3465@163.com.
Qiu-Ling WangDepartment of Endocrinology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Shandong, 264000, China. Wangql1123@163.com.
Jining Medical University · CNQingdao University · CNYuhuangding Hospital · CN

Funding

Key Research and Development Plan project of Shandong 2018GCF118137
6 · The paper itself

Abstract

At present, studies have found that latent Epstein-Barr virus (EBV) infection is associated with a variety of human tumours, and a vaccine is not available in this field. In this research, RT-PCR was used to obtain BZLF1 (immediately expressed early antigen Z) and LMP2 (latent membrane protein 2) cDNA from EBV. A ZLP2 fusion gene containing a linker sequence that encoded the polypeptide (Gly

Indexed as

Epstein-Barr Virus InfectionsNeoplasmsAnimalsBCG VaccineCD4-Positive T-LymphocytesHerpesvirus 4, HumanMiceMice, Inbred C57BLBCG VaccineEB virusRecombinant BCGTumourZLP2 fusion gene

Identifiers

PMID34854938
OpenAlexW3216121672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.